Interview with Laurent Verney, President, Depolabo
As the market leader in the French pre-wholesale market, Depolado had a quite impressive market share growth in the previous 3 years, now being responsible for a quarter of the…
Address: 102, Boulevard de Paris 13003 MARSEILLE,France
Tel: 04 91 28 15 00
Depolabo is the natural partner for pharmaceutical companies wishing to outsource storage and distribution to wholesalers, hospitals, pharmacies and other health professionals.
The pharmaceutical logistics operations are the heart of the historic business of Depolabo. The promotion and sale of products in pharmacies and derived services for commercial and marketing to health professionals Depolabo complete the offer. Today Depolabo proposes a global offer to its manufacturer customers.
Depolabo is the natural partner for pharmaceutical companies wishing to outsource storage and distribution to wholesalers, hospitals, pharmacies and other health professionals.
The pharmaceutical logistics operations are the heart of the historic business of Depolabo. The promotion and sale of products in pharmacies and derived services for commercial and marketing to health professionals Depolabo complete the offer. Today Depolabo proposes a global offer to its manufacturer customers.
As the market leader in the French pre-wholesale market, Depolado had a quite impressive market share growth in the previous 3 years, now being responsible for a quarter of the…
The president of the Institut Pasteur talks about how they must build on their differentiating factors, with a focus on interdisciplinary research, why they are not a French institute with…
Mr Martinez, President of Santen France, reveals how Santen’s decision to acquire the French pharmaceutical company Novagali in 2011, was based on its desire to project itself as an innovative ophthalmic…
The president of HAS sheds light on the seemingly complex French healthcare system, explains HAS’ role within that context and provides an honest assessment of the system’s advantages and flaws.…
Mr. Finn Søndergaard, CEO of Intsel Chimos, an independent French laboratory with a long history of expertise in the import of medicines for patients in a therapeutic impasse, highlights Intsel…
Mr. Michel Finance, CEO of Theradiag, a leading French player in in vitro diagnostics and the novel field of theranostics (a combination of treatment and diagnosis), discusses the major restructuring…
The president and founder of FSNB Health & Care, a healthcare consultancy, discusses his motivations behind the creation of his company, as well as the challenges and opportunities the pharmaceutical…
ALK’s Denis Delval reveals how France is number one in terms of volumes for the group and number two in terms of revenues, just behind Germany; how the four Danes…
The president and CEO of AREVA Med, the medical subsidiary of AREVA Group, the biggest nuclear company in the world, discusses the circumstances that inspired AREVA’s foray into nuclear medicine,…
The President of CEPS, the French pricing agency, reveals the issues around the launch of the hepatitis C drug Sovaldi in 2014 and of CEPS´ role to ensure that innovative products are available to all…
The President of Innothera talks about their unique business model, being in both the drug production and compression stockings businesses, how almost 95 percent of their drug production is exported,…
Olivier Pilley, French GM of the Swiss-American biotech company with a pioneering computational approach to anti-cancer therapies, presents ARIAD’s fascinating R&D model, his optimistic assessment of the competitiveness of the French…
The Director of the Social Security talks about the need to strengthen the sustainability of the French social security system, how France is attached to its unique system combining a…
See our Cookie Privacy Policy Here